je.st
news
FDA denies approval to expanded use of J&J/Bayer's Xarelto
2013-03-05 06:36:26| Biotech - Topix.net
Johnson & Johnson said health regulators denied approval to an expanded use of its blood thinner, Xarelto, to reduce the risk of heart attacks and strokes in patients with acute coronary syndrome.
Tags: expanded
approval
fda
denies
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||